RoidRagingBull Posted - 4 hours ago

$NKTX You know what I’d like to see around here! A huge dip, so I can really load up🤫!

anachartanalyst Posted - 6 hours ago

$NKTX https://anachart.com/wp-content/uploads/ana_temp/1732201316_soc-img.jpg

youbi336 Posted - 1 day ago

$FATE I invest in its competitor $NKTX but follow this closely. Why is the price target so low on this one? Seems to have a lot of potential...

Hatrak1 Posted - 2 days ago

$NKTX In for 1500 shares !

cheftonyd Posted - 2 days ago

$NKTX is this stock broken or what?

youbi336 Posted - 2 days ago

$NKTX Stifel Investor conference in 5 minutes https://wsw.com/webcast/stifel96/nktx/2136174

TheSleeeve Posted - 6 days ago

$NKTX Well....on the brightside at least we're near the 52 week low.

TheSleeeve Posted - 6 days ago

$NKTX Way more now.

TheSleeeve Posted - 6 days ago

$NKTX And to think this was 3.80 just a few days back.

TheSleeeve Posted - 1 week ago

$NKTX Good grief. Lol!

TheSleeeve Posted - 1 week ago

$NKTX Yikes. Needs a 35% gain just to get back to that head fake high a few days ago. Seems like someone wanted out and i dont blame em. Can't even get a technical bounce here. Junk.

youbi336 Posted - 1 week ago

$NKTX $KYTX A competitor to Nkarta will be sharing data of its KYV-101 study on Lupus Nephritis later this week. If the data is good, get ready for a trip down to $1.x "At ACR Convergence 2024 later this week, we will share the latest clinical data from lupus nephritis patients demonstrating the potential for durable treatment effect at the target clinical dose."

nightstocker15 Posted - 1 week ago

$NKTX trading at a market cap of only half of just the cash on hand not even including the pipeline.

Maxx25 Posted - 1 week ago

$NKTX in this chat are only shorts....fake bulls....

Maxx25 Posted - 1 week ago

$NKTX how the fuck is this buy but is going down in the last 6 months? When we go up?

TheSleeeve Posted - 1 week ago

$NKTX Need news in a bad way, Nikki. You're hurtin your shareholders here. Cure something already. This is pathetic.

youbi336 Posted - 1 week ago

$NKTX Nice! I see this going to $1.x now! Awesome, just awesome!

EpiCRise98 Posted - 1 week ago

$NKTX going long

EpiCRise98 Posted - 1 week ago

$NKTX meh will add 1.2k more shares to the pile

TheSleeeve Posted - 1 week ago

$NKTX Well I did warn ya fellas.

GPS_OS_21_vs_SOC_5 Posted - 1 week ago

$SLS The real key is the patient setting. Dying, no options. -- its why $NKTX Launched $500M in value on a small P1 trial. -- from 100k in volume to over 100M... in a day based on 10 patients. From what I can tell, the P2B Enrollment Began in April - (biopsies every 2 weeks) so there will have been 6 months of DATA from some of these patients, Plus more fulsome data from the P2A Optimally Dosed Asxl1+ patients, that may be / submitted to ASH for Late Breaker - which was due Oct 28. -- the CEO Linkdin stated more data coming in Q4. so not much time left if you take out Holidays. Then consider the actual ASH Pub data, most have no clue 009 has demonstrated 100% CR in asxl1+.

youbi336 Posted - 1 week ago

$NKTX For people who invest in this, what are your thoughts on Nkarta abandoning NKX019 for lymphoma?

TheSleeeve Posted - 1 week ago

$NKTX Shocking.

Maxx25 Posted - 1 week ago

$NKTX buy rating? How the fuck is this going down if it is a buy rating? American f......

EpiCRise98 Posted - 1 week ago

$NKTX 🎯 $16/$18/$20 - trade your plan

Thestocktraderhubzee Posted - 1 week ago

WATCHLIST NOV 12 2024. $DHX Barrington Research Maintains Outperform on DHI Group, Maintains $7 Price Target $LASR Needham Maintains Buy on nLight, Raises Price Target to $16 $SGC Barrington Research Maintains Outperform on Superior Gr of Cos, Raises Price Target to $21 $NKTX HC Wainwright & Co. Maintains Buy on Nkarta, Lowers Price Target to $18 $CME Deutsche Bank Maintains Hold on CME Gr, Lowers Price Target to $226

Ned_Nosurname Posted - 1 week ago

@youbi336 Too early to say. $CRSP is working with $NKTX on at least two products, but iPSCs allow a given cellular therapeutic to be produced from a single cell clone that harbours all the desired genetic manipulations, thus ensures homogeneity of the gene edits at the single cell level. The subsequent uniformed differentiation and expansion eliminate patient-to-patient or donor-to-donor manufacturing inconsistencies commonly seen in autologous and allogeneic donor-derived cell therapies.

Maxx25 Posted - 1 week ago

$NKTX how the fuck is this price target 18 and now cannot reach 4 you fucking moron's

youbi336 Posted - 1 week ago

$NKTX What do you guys think of FATE 825 update? I don't see NKTX competing with this and might be the reason they gave up on cancer... https://ir.fatetherapeutics.com/news-releases/news-release-details/fate-therapeutics-highlights-cancer-selective-her2-targeting

youbi336 Posted - 1 week ago

$NKTX Never trust a move without a catalyst